UK

India and the United Kingdom are poised to sign a long-anticipated Free Trade Agreement (FTA) on July 24, a move expected to unlock new avenues for bilateral trade, investment, and strategic cooperation. The pact, under negotiation since 2022, will address key sectors including goods, services, digital trade, and intellectual property. As two of the world’s most dynamic economies finalize terms, the agreement aims to eliminate or reduce tariffs, simplify market access, and enhance supply chain resilience.

Prime Minister Narendra Modi is scheduled to undertake a two-nation official tour to the United Kingdom and the Maldives from July 23 to 26, marking a significant diplomatic engagement during his current term. The visit is expected to focus on deepening bilateral relations, enhancing cooperation in areas such as trade, security, climate, and defense, and reaffirming India’s strategic presence in key global and regional spheres.

In a strategic move to strengthen its presence in the global credit management and collections space, Firstsource Solutions has acquired Pastdue Credit Solutions (PCS), a leading UK-based debt resolution and recovery firm. This acquisition aligns with Firstsource’s broader growth strategy of expanding its financial services capabilities across key international markets. The deal will provide Firstsource with access to PCS’s well-established client base, specialized collections technology, and regulatory expertise in the UK’s evolving consumer finance ecosystem.

India and the United Kingdom are poised to sign a long-anticipated Free Trade Agreement (FTA) next week, ushering in a new era of economic partnership between the two democracies. The agreement, under negotiation for over two years, is expected to reduce tariffs, enhance market access, and strengthen strategic cooperation across sectors such as services, technology, manufacturing, and pharmaceuticals. This landmark deal reflects a broader geopolitical shift, as both nations seek to diversify trade relations in a post-Brexit, post-pandemic global economy.

In a landmark moment for reproductive science and genetic medicine, the United Kingdom has successfully welcomed eight healthy babies conceived through mitochondrial donation treatment (MDT)—a pioneering form of in-vitro fertilization (IVF) involving DNA from three individuals. This breakthrough marks the first time in British medical history that MDT has been used to prevent the transmission of rare but often fatal mitochondrial diseases from mother to child.

Tata Steel has announced a landmark Rs. 10,400 crore (approximately GBP 1.25 billion) investment to overhaul its Port Talbot facility in Wales, marking one of the largest industrial decarbonization initiatives in the United Kingdom. This ambitious plan will replace aging blast furnaces with state-of-the-art electric arc furnaces, significantly reducing carbon emissions and safeguarding thousands of jobs.

In a decisive push to safeguard and advance its strategic interests in global satellite infrastructure, the United Kingdom has stepped in as a key investor in Eutelsat’s €1.5 billion capital raise. This commitment comes as the Paris-headquartered satellite giant seeks to fortify its balance sheet and expedite the rollout of next-generation connectivity services. By participating in this substantial equity offering, the UK not only underpins critical technological capabilities but also bolsters its geopolitical influence in the high-stakes arena of space-based communications.

In a move poised to elevate India’s position in global medical innovation, Max Healthcare has entered into a strategic partnership with the UK’s Aston University to collaborate on advanced clinical research. This alliance aims to deepen investigations into oncology, neurosciences, and emerging healthcare technologies, fostering cross-border expertise and accelerating the translation of scientific breakthroughs into patient care.

Biocon Ltd’s subsidiary, Biocon Biologics Ltd, has obtained marketing authorizations from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for two Denosumab biosimilars, Vevzuo and Evfraxy. These approvals mark a significant advancement in the company’s international expansion in biosimilar therapeutics, targeting bone-related ailments such as skeletal complications in advanced cancers, osteoporosis, and bone loss due to hormone therapy.

Artificial intelligence is driving transformative change in medical imaging at Hull University Teaching Hospitals NHS Trust, where the integration of deep learning software into MRI systems has significantly reduced scan times. By leveraging advanced algorithms, clinicians can now produce sharper images more efficiently, increasing patient throughput while maintaining diagnostic precision. The initiative, currently in use at Hull Royal Infirmary and Castle Hill Hospital, has also improved accessibility for vulnerable patients, including children and individuals with claustrophobia.